162 related articles for article (PubMed ID: 8547211)
1. Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.
Sakata K; Hoshino T; Yoshida H; Kaburagi T; Takada A
Cardiovasc Drugs Ther; 1995 Aug; 9(4):601-7. PubMed ID: 8547211
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of vasospastic angina with exercised-induced ischemia--analysis of parameters of hemostasis and fibrinolysis.
Sakata K; Hoshino T; Yoshida H; Shugino H; Miura F; Takada A
Jpn Circ J; 1996 May; 60(5):277-84. PubMed ID: 8803721
[TBL] [Abstract][Full Text] [Related]
3. Beraprost sodium protects occlusion/reperfusion injury in the dog by inhibition of neutrophil migration.
Ueno Y; Miyauchi Y; Nishio S
Gen Pharmacol; 1994 May; 25(3):427-32. PubMed ID: 7926586
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.
Kim M; Kim JU; Kim SM; Kim H
Int Urol Nephrol; 2017 Jul; 49(7):1287-1295. PubMed ID: 28409403
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin analogue, beraprost, sustains recanalization duration after thrombolytic therapy in acute myocardial infarction model.
Saito T; Saitoh S; Asakura T; Kanke M; Owada K; Maruyama Y
Int J Cardiol; 1993 Mar; 38(3):225-33. PubMed ID: 8463004
[TBL] [Abstract][Full Text] [Related]
6. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
Nony P; Ffrench P; Girard P; Delair S; Azoulay S; Girre JP; Dechavanne M; Boissel JP
Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
[TBL] [Abstract][Full Text] [Related]
7. A dose-effect study of beraprost sodium in intermittent claudication.
Lievre M; Azoulay S; Lion L; Morand S; Girre JP; Boissel JP
J Cardiovasc Pharmacol; 1996 Jun; 27(6):788-93. PubMed ID: 8761844
[TBL] [Abstract][Full Text] [Related]
8. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
Alexandrou K; Hata Y; Matsuka K; Matsuda H
Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
[TBL] [Abstract][Full Text] [Related]
9. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T
Burns; 1996 Nov; 22(7):531-8. PubMed ID: 8909753
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy.
Ueno Y; Koike H; Nishio S
J Cardiovasc Pharmacol; 1995 Oct; 26(4):603-7. PubMed ID: 8569222
[TBL] [Abstract][Full Text] [Related]
11. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.
Mahmarian JJ; Fenimore NL; Marks GF; Francis MJ; Morales-Ballejo H; Verani MS; Pratt CM
J Am Coll Cardiol; 1994 Jul; 24(1):25-32. PubMed ID: 8006274
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris.
Lai CP; Egashira K; Tashiro H; Narabayashi H; Koyanagi S; Imaizumi T; Takeshita A
Circulation; 1993 Jan; 87(1):144-51. PubMed ID: 8419001
[TBL] [Abstract][Full Text] [Related]
13. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
14. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation.
Okada Y; Marchevsky AM; Kass RM; Matloff JM; Jordan SC
Transplantation; 1998 Nov; 66(9):1132-6. PubMed ID: 9825806
[TBL] [Abstract][Full Text] [Related]
15. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography.
Mahmarian JJ; Pratt CM; Cocanougher MK; Verani MS
Circulation; 1990 Oct; 82(4):1305-15. PubMed ID: 2401064
[TBL] [Abstract][Full Text] [Related]
16. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
Mohler ER; Hiatt WR; Olin JW; Wade M; Jeffs R; Hirsch AT
J Am Coll Cardiol; 2003 May; 41(10):1679-86. PubMed ID: 12767646
[TBL] [Abstract][Full Text] [Related]
17. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy.
Nesto RW; Phillips RT; Kett KG; Hill T; Perper E; Young E; Leland OS
Ann Intern Med; 1988 Feb; 108(2):170-5. PubMed ID: 3341650
[TBL] [Abstract][Full Text] [Related]
18. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
[TBL] [Abstract][Full Text] [Related]
19. [The value of thallium myocardial scintigraphy (single photon emission computerized tomography, SPECT) for diagnosis of ischemia after myocardial infarct].
Fries P; Thimme W; Haubold R
Med Klin (Munich); 1994 Nov; 89(11):582-6. PubMed ID: 7815985
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of beraprost sodium on Raynaud's phenomenon in patients with systemic sclerosis].
Kaburaki J; Kuwana M; Akizuki M; Takano M; Tojo T
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):29-35. PubMed ID: 7553036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
